Clinical Trial Update: A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13 [Phase 3]

View source ↗

Summary

This update reports the completion of a multicentre, randomized Phase III trial evaluating rituximab as maintenance therapy versus observation in aggressive B-c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma Grade 3b

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Follicular NHL Grade 3b | Phase 3 | Status: COMPLETED